论文部分内容阅读
近年来,我们用罗钙全治疗22例CAPD病人,观察了治疗前后血清钙磷、甲状旁腺激素(iPTH)和骨矿含量变化,报告如下。 资料和方法 22例住院CAPD病人,男16例,女6例。年龄18～76岁。慢性肾炎12例,高血压肾病6例,慢性肾盂肾炎2例,多囊肾病和糖尿病肾病各1例,均为尿毒症期。CAPD3～28月。用药前测血清钙、磷、总蛋白、白蛋白、iPTH,硷性磷酸酶等。口服罗钙全0.25ug/日。每月复查以上指标。治疗前和用药三月后采用单光子吸收法检测骨矿含量。桡骨中下段1/3处为骨矿线密度(BMC)和骨矿面密度(BMD),数据采用t检验。。 结果 服药后病人乏力及骨痛症状缓解。血钙、磷,iPTH变化见附表,治疗1月后,
In recent years, we treated 22 cases of CAPD with Luo calcium all patients, observed before and after treatment of serum calcium and phosphorus, parathyroid hormone (iPTH) and bone mineral content changes, the report is as follows. Materials and Methods Twenty-two hospitalized CAPD patients, 16 males and 6 females. Age 18 to 76 years old. Chronic nephritis in 12 cases, 6 cases of hypertensive nephropathy, chronic pyelonephritis in 2 cases, polycystic kidney disease and diabetic nephropathy in 1 case, are uremia. CAPD3 ~ 28 months. Before treatment, serum calcium, phosphorus, total protein, albumin, iPTH, alkaline phosphatase and so on. Oral calcium full 0.25ug / day. Monthly review of the above indicators. Bone mineral content was measured by single photon absorption before treatment and after treatment. The middle and lower third of the radial bone mineral density (BMC) and bone mineral density (BMD), the data using t test. . Results After taking the patient’s fatigue and pain relief. Blood calcium, phosphorus, iPTH changes in Schedule, treatment in January,